[go: up one dir, main page]

BR9708179A - Bioconjugates of manganese or iron complexes of nitrogen-containing macrocyclic binders effective as catalysts for demuting superoxides - Google Patents

Bioconjugates of manganese or iron complexes of nitrogen-containing macrocyclic binders effective as catalysts for demuting superoxides

Info

Publication number
BR9708179A
BR9708179A BR9708179A BR9708179A BR9708179A BR 9708179 A BR9708179 A BR 9708179A BR 9708179 A BR9708179 A BR 9708179A BR 9708179 A BR9708179 A BR 9708179A BR 9708179 A BR9708179 A BR 9708179A
Authority
BR
Brazil
Prior art keywords
demuting
bioconjugates
superoxides
catalysts
manganese
Prior art date
Application number
BR9708179A
Other languages
Portuguese (pt)
Inventor
William L Neumann
Dennis P Riley
Randy H Weiss
Susan L Henke
Patrick J Lennon
Karl W Aston
Original Assignee
Monsanto Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1996/012767 external-priority patent/WO1997006824A2/en
Application filed by Monsanto Co filed Critical Monsanto Co
Publication of BR9708179A publication Critical patent/BR9708179A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00Compounds containing elements of Groups 7 or 17 of the Periodic Table
    • C07F13/005Compounds without a metal-carbon linkage
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D259/00Heterocyclic compounds containing rings having more than four nitrogen atoms as the only ring hetero atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/02Iron compounds
    • C07F15/025Iron compounds without a metal-carbon linkage

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR9708179A 1996-03-13 1997-03-04 Bioconjugates of manganese or iron complexes of nitrogen-containing macrocyclic binders effective as catalysts for demuting superoxides BR9708179A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1334896P 1996-03-13 1996-03-13
PCT/US1996/012767 WO1997006824A2 (en) 1995-08-17 1996-08-14 Bioconjugates of manganese complexes and their application as catalysts
PCT/US1997/002566 WO1997033877A1 (en) 1996-03-13 1997-03-04 Bioconjugates of manganese or iron complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide

Publications (1)

Publication Number Publication Date
BR9708179A true BR9708179A (en) 1999-07-27

Family

ID=21759507

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9708179A BR9708179A (en) 1996-03-13 1997-03-04 Bioconjugates of manganese or iron complexes of nitrogen-containing macrocyclic binders effective as catalysts for demuting superoxides

Country Status (11)

Country Link
EP (1) EP0891338A1 (en)
JP (1) JP2000508625A (en)
KR (1) KR19990087784A (en)
CN (1) CN1225631A (en)
AU (1) AU1962497A (en)
BR (1) BR9708179A (en)
CA (1) CA2249011A1 (en)
CZ (1) CZ271198A3 (en)
IL (1) IL125889A0 (en)
NO (1) NO984164L (en)
WO (1) WO1997033877A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6127356A (en) 1993-10-15 2000-10-03 Duke University Oxidant scavengers
US6214817B1 (en) * 1997-06-20 2001-04-10 Monsanto Company Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity
US6180620B1 (en) 1997-06-20 2001-01-30 G.D. Searle & Co. Analgesic methods using synthetic catalysts for the dismutation of superoxide radicals
EP1045851B1 (en) 1997-11-03 2003-04-23 Duke University Substituted porphyrins
EP1616869B1 (en) 1999-01-25 2012-04-04 National Jewish Health Substituted porphyrins and their therapeutic use
WO2000054784A1 (en) * 1999-03-15 2000-09-21 Abdurafik Bakhramovich Akbarov Complex comprising the coordination compound manganese, its medical effects and the mode of its production
JP2003500174A (en) * 1999-05-27 2003-01-07 フアルマシア・コーポレーシヨン Biomaterials modified with superoxide dismutase mimics
US20050176790A1 (en) 2001-02-28 2005-08-11 Johannes Bartholomaus Pharmaceutical salts
WO2002098431A1 (en) 2001-06-01 2002-12-12 National Jewish Medical And Research Center Oxidant scavengers for treatment of diabetes or use in transplantation or induction of immune tolerance
WO2003103680A1 (en) 2002-06-07 2003-12-18 Duke University Substituted porphyrins
EP2300032A4 (en) 2008-05-13 2012-12-05 Univ Kansas METAL ABSTRACTIONSPEPTID (MAP) DAY AND RELEVANT PROCEDURES
ES2600469T3 (en) 2008-05-23 2017-02-09 National Jewish Health A compound for use in the treatment of lesions associated with exposure to phosgene gas or chlorine gas
US9187735B2 (en) 2012-06-01 2015-11-17 University Of Kansas Metal abstraction peptide with superoxide dismutase activity

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0524161A1 (en) * 1991-07-19 1993-01-20 Monsanto Company Manganese complexes of nitrogen containing macrocyclic ligands effective as catalysts for dismutating superoxide
CA2103554C (en) * 1991-12-10 2002-07-30 Garry E. Kiefer Bicyclopolyazamacrocyclocarboxylic acid complexes, their conjugates, processes for their preparation, and use as contrast agents
US5747026A (en) * 1993-10-15 1998-05-05 University Of Alabama At Birmingham Research Foundation Antioxidants
AU6031096A (en) * 1995-06-05 1996-12-24 Duke University Nitrosylated and nitrated superoxide oxidants and reductants
US6525041B1 (en) * 1995-06-06 2003-02-25 Pharmacia Corporation Manganese or iron complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide
JPH11507621A (en) * 1995-06-07 1999-07-06 モンサント カンパニー Process for producing substituted polyaza macrocycles

Also Published As

Publication number Publication date
IL125889A0 (en) 1999-04-11
NO984164D0 (en) 1998-09-10
NO984164L (en) 1998-11-06
CZ271198A3 (en) 1999-01-13
WO1997033877A1 (en) 1997-09-18
CN1225631A (en) 1999-08-11
CA2249011A1 (en) 1997-09-18
JP2000508625A (en) 2000-07-11
AU1962497A (en) 1997-10-01
EP0891338A1 (en) 1999-01-20
KR19990087784A (en) 1999-12-27

Similar Documents

Publication Publication Date Title
BR9708179A (en) Bioconjugates of manganese or iron complexes of nitrogen-containing macrocyclic binders effective as catalysts for demuting superoxides
BR9711530A (en) Combination of therapy for the treatment of psychoses
AU6023796A (en) Manganese or iron complexes of nitrogen-containing macrocycl ic ligands effective as catalysts for dismutating superoxide
HUP0900652A2 (en) Metal compounds, mixed or sulphated, as phosphate binders
DE69727045D1 (en) RADIO THERAPY TABLE
AP9901455A0 (en) Long-lived homogenous oxidation catalyst
HUP1500179A2 (en) The use of human tnf-alpha binding antibodies
AP9700977A0 (en) Inclusion complexes of aryl-heterocyclic salts
ZA988503B (en) Mixed bed iron reduction process
BR9610347A (en) Bioconjugates of manganese complexes of nitrogen-containing macrocyclic binders effective as catalysts for superoxide dismutation
BR9612412A (en) 3-Azetidinylalkylpiperidines or pyrrolidines as tachykinin antagonists
HUP9902411A3 (en) Oxidation catalyst
BR9707978A (en) Iron complexes of nitrogen-containing macrocyclic binders effective as catalysts for superoxide dismutation
FI970972A0 (en) Perlitic gray iron for brake components
EP0867614A4 (en) Rotary type hydraulic transformer
IL148815A0 (en) Substituted pyrroles as antiproliferative agents for the treatment of cancer
PT9420T (en) COVER FOR VEHICLE WHEELS
ES1034961Y (en) VEHICLE FLOOR MAT.
HU9603234D0 (en) Catalytic composition for the oxidative ammonolysis of alkylpyridines
KR970057624U (en) Car Bed
PL312548A1 (en) Low-alloy aluminium-free steel of increased strength
KR970061335U (en) Car body cover
PL314569A1 (en) Low-alloy constructional cast steels
SI1224181T1 (en) Substituted pyrroles as antiproliferative agents for the treatment of cancer
ES1032889Y (en) MEANS FOR ELIMINATION OF ODORS IN SANITARIES.

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]